She has over 20 years of experience in integrative and functional nutrition and has given lectures to health professionals and consumers on nutrition, dietary supplements and related health issues
GLP-1 receptor agonists are prescribed to manage type 2 diabetes by regulating blood sugar and, in some cases, to support weight loss
We look for the hidden barriers to weight loss, such as: Insulin Resistance: The inability to process sugar efficiently, leading to fat storage
24,29 Through this receptor, GLP-1 leads to an increase of cAMP levels that thereafter activates protein kinase A (PKA)
In a systematic review of seven randomized controlled trials for people with type 2 diabetes published in Diabetes Therapy, researchers compared the efficacy data of GLP-1 injectable medications to the oral semaglutide pill
Retatrutide, a GIP, GLP-1 and glucagon receptor agonist, for people with type 2 diabetes: a randomised, double-blind, placebo and active-controlled trial
/assets/images/provider/photos/2788220.png)
